Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

CCI approves acquisition of certain business undertakings of Ind Swift Labs, Essix Biosciences by Synthimed Labs

Ruchika Sharma22 Dec 2023 1:00 PM IST

New Delhi: The Competition Commission of India (CCI) has approved the proposed acquisition of certain business undertakings of Ind Swift...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck gets European Commission nod for two new indications for Keytruda in gastrointestinal cancers

Ruchika Sharma22 Dec 2023 11:00 AM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the European Commission (EC) has approved two new indications...

Jan Aushadhi Kendras Can Continue in Govt Hospitals, Rules Karnataka High Court

Pradhan Mantri Bhartiya Janaushadhi Pariyojana achieves target of Rs 1000 crore in sales in FY 2023-24

Ruchika Sharma22 Dec 2023 10:00 AM IST

New Delhi: Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) has created another landmark in the history of generic medicines in the country...

USFDA grants priority review to Merck investigational 21-valent Pneumococcal Conjugate Vaccine specifically designed to protect adults

Ruchika Sharma21 Dec 2023 3:47 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Food and Drug Administration (FDA) has accepted for...

CCI approves acquisition of majority shareholding of Glenmark Life Sciences by Nirma

Ruchika Sharma21 Dec 2023 2:52 PM IST

New Delhi: The Competition Commission of India (CCI) has approved acquisition of majority shareholding of the Glenmark Life Sciences Limited by...

Adverse drug reactions from normal saline: Punjab imposes 3-year ban on Captab Biotech

CDSCO bans use of Chlorpheniramine Maleate IP 2mg and Phenylephrine HCL IP 5mg drop/ml FDC in kids below 4 years

Ruchika Sharma21 Dec 2023 2:19 PM IST

New Delhi: To ensure the safety of infants and young children in the country, the Central Drugs Standard Control Organization (CDSCO) has...

Recall of Philips medical imaging devices classified as most serious by USFDA

Ruchika Sharma21 Dec 2023 12:30 PM IST

The use of an affected system may cause serious adverse health consequences, including chemical exposure, lack of oxygen and tissue damage, according...

USFDA declines to approve Merck chronic cough drug Gefapixant

Ruchika Sharma21 Dec 2023 11:30 AM IST

New Jersey: The U.S. Food and Drug Administration (FDA) declined to approve Merck's drug for chronic cough, the company said on Wednesday,...

Provide GST exemption on import of pharma products used in life-saving medicines research: Parliamentary panel asks Centre

Ruchika Sharma20 Dec 2023 5:00 PM IST

"The committee are also of the view that hospitals carrying out research on life-saving medicines and treatment may also be considered for being...

Aurobindo Pharma arm API facility gets 3 observations from USFDA

USFDA issues EIR for Aurobindo Pharma arm AP facility

Ruchika Sharma20 Dec 2023 3:41 PM IST

Hyderabad: Aurobindo Pharma has announced that the U.S. Food and Drug Administration (USFDA) has issued an Establishment Inspection Report (EIR)...

Jemperli plus Zejula combo significantly improved progression-free survival in primary advanced or recurrent endometrial cancer: GSK

Ruchika Sharma20 Dec 2023 2:30 PM IST

London: GSK plc has announced positive headline results from a planned analysis of Part 2 of the RUBY/ENGOT-EN6/GOG3031/NSGO phase III trial...

GSK, Pfizer resolve patent lawsuit over RSV vaccines

Pfizer, BioNTech sues Poland, Hungary over Covid debts

Ruchika Sharma20 Dec 2023 1:30 PM IST

Brussels: Pharmaceutical firms Pfizer and BioNTech are suing the governments of Poland and Hungary alleging they failed to pay for vaccines...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok